PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of nihpaAbout Author manuscriptsSubmit a manuscriptHHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
 
Am J Med Genet A. Author manuscript; available in PMC 2013 November 1.
Published in final edited form as:
PMCID: PMC3477281
NIHMSID: NIHMS378633

Overt Cleft Palate Phenotype and TBX1 Genotype Correlations in Velo-cardio-facial/DiGeorge/22q11.2 Deletion Syndrome Patients

Abstract

Velo-cardio-facial syndrome/DiGeorge syndrome, also known as 22q11.2 deletion syndrome (22q11DS) is the most common microdeletion syndrome, with an estimated incidence of 1/2,000 – 1/4,000 live births. Approximately 9–11% of patients with this disorder have an overt cleft palate (CP), but the genetic factors responsible for CP in the 22q11DS subset are unknown. The TBX1 gene, a member of the T-box transcription factor gene family, lies within the 22q11.2 region that is hemizygous in patients with 22q11DS. Inactivation of one allele of Tbx1 in the mouse does not result in CP, but inactivation of both alleles does. Based on these data, we hypothesized that DNA variants in the remaining allele of TBX1 may confer risk to CP in patients with 22q11DS. To test the hypothesis, we evaluated TBX1 exon sequencing (n = 360) and genotyping data (n = 737) with respect to presence (n = 54) or absence (n = 683) of CP in patients with 22q11DS. Two upstream SNPs (rs4819835 and rs5748410) showed individual evidence for association but they were not significant after correction for multiple testing. Associations were not identified between DNA variants and haplotypes in 22q11DS patients with CP. Overall, this study indicates that common DNA variants in TBX1 may be nominally causative for CP in patients with 22q11DS. This raises the possibility that genes elsewhere on the remaining allele of 22q11.2 or in the genome could be relevant.

Keywords: 22q11.2 deletion syndrome, TBX1 sequencing, cleft palate, genomic disorder

INTRODUCTION

Overt cleft palate (CP) is one of the most common birth defects in humans occurring in one per 1,000 live births [Gorlin 2001]. This phenotype occurs commonly in association with many genetic syndromes such as velo-cardio-facial syndrome (OMIM#192430) [Shprintzen et al., 1978] /DiGeorge syndrome (OMIM#188400) [DiGeorge, 1965], or 22q11.2 deletion syndrome (22q11DS). Approximately 9–11% of patients with 22q11DS have an overt cleft of the bony palate, while the rest have mild craniofacial features [Kobrynski and Sullivan 2007; McDonald-McGinn et al., 1999; Hopper et al., 2007].

The TBX1 gene, a member of the T-box gene family lies within the 22q11.2 region that is hemizygous in patients [Chieffo et al., 1997]. Homozygous Tbx1 null mutant mice display a spectrum of 22q11DS related phenotypes including CP, but inactivation of one allele of Tbx1 in the mouse does not result in CP [Lindsay, 2001; Merscher et al., 2001]. Based upon studies of mouse Tbx1−/− mutants we hypothesized that DNA variants in TBX1 on the remaining allele cause CP. The purpose of the study was to analyze the sequencing and genotyping data with respect to presence or absence of CP in a group of patients with 22q11DS.

MATERIALS AND METHODS

Human Subjects

Informed consent was obtained for all participants according to an IRB-approved protocol (1999–201). Blood or saliva samples were obtained from patients with 22q11DS [Guo et al., 2011]. The cohort used for analysis was self-reported as Caucasian. In our 22q11DS cohort, 1,022 patients had DNA samples and 737 of these patients had diagnosed craniofacial findings. Among the 737 Patients, 54 patients had CP (Fig 1).

Figure 1
Methods flow chart detailing the resequencing and genotyping cohorts

TBX1 Resequencing and Genotyping

We had DNA sequence results for 360, of whom 328 had craniofacial data and 20 had CP [Guo et al., 2011]. All 737 DNAs were genotyped and in total, 20 patients with CP had TBX1 DNA sequence data. A detailed description of the DNA sequence analysis of the TBX1 exons can be found in Guo et al.,, [2011]. The SNPs (hg18, 2006) were assigned to linkage disequilibrium (LD) blocks using TBX1 resequencing data from 360 patients (Supplementary Figure 1) [Guo et al., 2011]. Based on the LD structure of the locus, 16 common SNPs and two additional SNPs from the 5'-flanking region were selected because they covered each LD block and thus served as tagSNPs for genotyping the 1,022 subjects. Primer sequences are available on request.

Statistical analyses

Chi-square (χ2) test was used to evaluate associations between the “genotype” (allele) and individual phenotypes (Supplementary Table II). Since the TBX1 gene is located within the 22q11.2 deletion region, and all proband DNAs have one copy of the gene, their individual haplotypes were directly observed [Guo et al., 2011]. Variants with a MAF less than 0.01, amounting to 45 were treated as very rare SNP variations [Guo et al., 2011].

Method 1, rare SNP variant analysis: A simple contingency table was constructed to test for differences in the total number of rare SNP variations in the CP group versus the rest of the patients with 22q11DS but without CP. Method 2, rare SNP variant analysis: The rare SNP variant allele counts were collapsed mathematically, by assigning each individual a carrier/non-carrier status. This was based on the presence or absence of rare SNP variant minor alleles. A simple contingency table was constructed to test for differences in rare SNP variant minor allele frequency between cases and controls as described [Guo et al., 2011].

RESULTS

Overt cleft palate in our 22q11DS cohort

All of the 737 patients with 22q11DS in this study had a recorded craniofacial anomaly, although not all craniofacial features besides CP were reported at all research sites. Overt cleft palate (CP) occurs in 9–11% of patients with 22q11DS (Table I), which is a frequency of 10 fold over that in the general population. A total of 54 patients (7.3%) in our cohort had CP (Figure 1). This included 29 females and 25 males. There was no significant difference in the prevalence of CP between the two genders (p=0.89).

TBX1 resequencing

The hypothesis we tested was whether mutations in the remaining allele of TBX1 might cause CP. We searched for mutations in exons of TBX1 in existing DNA sequence data from 20 patients with CP in the cohort of 360 consecutive subjects with 22q11DS that were sequenced [Guo et al., 2011]. We did not find evidence for association with common, or rare SNP variants. Among the 20 patients with CP and 22q11DS that were sequenced, none had predicted pathogenic missense or nonsense mutations. Since the TBX1 gene is located within the 22q11.2 deletion region, and all patient DNAs have one copy of the gene, their individual haplotypes could be directly observed. Among the 20 individuals with CP, 17 haplotypes were identified (Supplementary eTable I – see Supporting Information online), but we did not find enrichment of specific haplotypes.

TBX1 re-sequencing rare enrichment findings

It has been suggested that enrichment of rare SNP variants, within particular phenotypes could indicate a genetic association with a particular phenotype [Conti et al., 2003; Gong et al., 2001; Griffin et al., 2010; Paylor et al., 2006; Rauch et al., 2004; Torres-Juan et al., 2007; Yagi et al., 2003; Zweier et al., 2007]. We performed a rare SNP variant enrichment analysis on 328 samples with sequence and phenotype data, 20 of which had CP. When analyzed via Method 1 and Method 2, there was no significant difference in the total number of rare SNP variants or rare SNP enrichment in patients with CP versus those with or without any other recorded palatal defect.

Genotype analysis

To determine if common SNPs in the TBX1 locus were associated with CP, we examined genotype data in 737 subjects, of which 54 had CP, with available data on common SNPs by direct genotyping (Fig 1). Based upon the DNA sequence analysis of the 360 patients, we identified 16 tagSNPs in three distinct LD blocks (Supplementary eFigure 1 – See Supporting Information online). The SNPs (MAF 0.07–0.44) were used to genotype 737 subjects, 54 of which expressed the CP phenotype [Guo et al., 2011]. We found two nearby SNPs (824 bp apart), rs4819835 and rs5748410, 26 kb upstream of the first exon that showed nominal significance but failed to show significance after correcting for multiple testing (Fig 2; Fig 3). This SNP, rs5748410 was also nominally significant when subjects with CP were compared to those with SCP, OSCP, or BU (p<0.04). Of note, the two SNPs are not in LD (R2=0.004, D'=0.09), thus they are independent, and they are not conserved in mammalian species (Fig 4C).

Figure 2
Representative common SNPs in the TBX1 locus, CP phenotype group in 22q11DS and SNP association values
Figure 3
SNP rs4819835: Genotype-phenotype correlations and allele frequencies for the overt cleft palate phenotype
Figure 4
Evaluation of SNPs rs5748410 and rs4819835 upstream of TBX1

DISCUSSION

In this study, we analyzed DNA sequence and genotype data in our cohort of 737 patients with 22q11DS [Guo et al.,, 2011] for association with CP. We found that the remaining TBX1 gene on 22q11.2 is not a major risk factor for CP in 22q11DS. Even though the two SNPs found upstream of TBX1 (rs5748410; rs4819835) were not statistically significant after correcting for multiple testing, they are interesting biologically, since they lie in the upstream region that could tag potential regulatory SNPs. One possibility is that these SNPs mark DNA variants that directly alter TBX1 expression levels thus changing risk of having the CP phenotype as secondary to the deletion on chromosome 22. Unfortunately, both SNPs are in a region that does not have well-defined LD blocks (Figure 4). Further functional studies using mouse models need to address if the variants in this region tagged by the SNPs identified could regulate the gene expression of Tbx1.The CP phenotype includes a cleft of the bony and soft palates, as compared to a cleft of the soft palate alone (SCP and OSCP), thus representing a more severe abnormality, with developmentally distinct origins [Moore and Persaud, 2003; Gorlin et al, 2001]. Of note, the CP patients represented a diagnostically reliable phenotype when examining this population. Some of the more subtle palatal features (SCP, OSCP, BU; Fig 2) were not always scored and therefore were not a focus of this investigation. Although this may have contributed to the current study's failure to reject the null hypothesis, a relatively small sample size, as well as the complexity of data processing may have also played a role despite attempts at surveillance and statistical correction. Implementing a protocol for phenotype diagnosis and further deep genotype resequencing could also improve the data quality.

In this report, we tested TBX1-genotype correlations in patients with CP and 22q11DS. Our results suggest a possible association between two adjacent SNPs upstream of TBX1 and the CP phenotype, but were not significant after correcting for multiple testing. Over 400 Mendelian disorders in which clefting occurs have been reported and studies have suggested that many candidate genes may be responsible (http://www.ncbi.nlm.nih.gov/oOMIM). Although many candidate genes have been reported, the identification of clear correlations between genetic mutations and the cleft phenotype has been complicated by genetic and allelic heterogeneity, incomplete penetrance, and phenotypic variability [Jugessur et al.,, 2009]. Additionally, few reports have focused on CP without cleft lip involvement. Focusing attention to the overlapping pathways between these previously identified loci and TBX1 may be of interest. By examining the CP phenotype in a larger sample size of patients with 22q11DS, future studies could focus attention on the other allele of 22q11.2 or elsewhere in the genome. Alternatively, investigation of other syndromic and nonsyndromic cases of CP may yield better understanding of the complex genetic pathways that shape the craniofacial complex.

Supplementary Material

Supplemental Figure S1

Supplemental Tables S1-S2

ACKNOWLEDGMENTS

We thank the families affected by 22q11DS, as well as numerous clinicians for their participation in our study. The genetic assays and DNA isolation was performed in the Genomics and Molecular Cytogenetics Cores at Einstein, respectively. We thank Dr. Silvia Racedo, Dr. Ping Kong, Dr. Laina Freyer, Maria Delio, Dennis Monks, David Sweet, Noah Kolatch, Raquel Castellanos, and Stephania Macchiarulo for technical assistance

Funding We gratefully acknowledge funding from NIH grant HL084410 and P01HD070454 that provided support. These studies were also partially supported by funds from the Charles E.H. Upham Chair (BSE).

REFERENCES

  • Chieffo C, Garvey N, Gong W, Roe B, Zhang G, Silver L, Emanuel BS, Budarf ML. Isolation and characterization of a gene from the DiGeorge chromosomal region homologous to the mouse Tbx1 gene. Genomics. 1997;43:267–277. [PubMed]
  • Conti E, Grifone N, Sarkozy A, Tandoi C, Marino B, Digilio MC, Mingarelli R, Pizzuti A, Dallapiccola B. DiGeorge subtypes of nonsyndromic conotruncal defects: evidence against a major role of TBX1 gene. Eur J Hum Genet. 2003;11:349–351. [PubMed]
  • Gong W, Gottlieb S, Collins J, Blescia A, Dietz H, Goldmuntz E, McDonald-McGinn DM, Zackai EH, Emanuel BS, Driscoll DA, Budarf ML. Mutation analysis of TBX1 in non-deleted patients with features of DGS/VCFS or isolated cardiovascular defects. J Med Genet. 2001;38:E45. [PMC free article] [PubMed]
  • Gorlin RJ, Cohen MM, Hennekam RCM. Syndromes of the Head and Neck. 4 edn. Oxford University Press; New York, NY: 2001.
  • Griffin HR, Topf A, Glen E, Zweier C, Stuart AG, Parsons J, Peart I, Deanfield J, O'Sullivan J, Rauch A, Scambler P, Burn J, Cordell HJ, Keavney B, Goodship JA. Systematic survey of variants in TBX1 in non-syndromic tetralogy of Fallot identifies a novel 57 base pair deletion that reduces transcriptional activity but finds no evidence for association with common variants. Heart. 2010;96:1651–1655. [PMC free article] [PubMed]
  • Guo T, McDonald-McGinn D, Blonska A, Shanske A, Bassett AS, Chow E, Bowser M, Sheridan M, Beemer F, Devriendt K, Swillen A, Breckpot J, Digilio MC, Marino B, Dallapiccola B, Carpenter C, Zheng X, Johnson J, Chung J, Higgins AM, Philip N, Simon TJ, Coleman K, Heine-Suner D, Rosell J, Kates W, Devoto M, Goldmuntz E, Zackai E, Wang T, Shprintzen R, Emanuel B, Morrow B. Genotype and cardiovascular phenotype correlations with TBX1 in 1,022 velo-cardio-facial/digeorge/22q11.2 deletion syndrome patients. Hum Mutat. 2011;32:1278–1289. [PMC free article] [PubMed]
  • Hopper RA, Cutting C, Grayson B. Cleft Lip and Palate. In: Thorne CHBS, Beasley RW, Aston SJ, Gurtner GC, Spear SL, editors. Grabb and Smith's Plastic Surgery. 6 edn. Wolters Kluwer Health/ Lippincott Williams & Wilkns; Philadelphia: 2007. pp. 201–225.
  • Jugessur A, Farlie PG, Kilpatrick N. the genetics of isolated orofacial clefts: from genotypes to subphenotypes. Oral Diseases. 2009;15:437–453. [PubMed]
  • Kobrynski LJ, Sullivan KE. Velocardiofacial syndrome, DiGeorge syndrome: the chromosome 22q11.2 deletion syndromes. Lancet. 2007;370:1443–1452. [PubMed]
  • Lindsay EA. Chromosomal microdeletions: dissecting del22q11 syndrome. Nat Rev Genet. 2001;2:858–868. [PubMed]
  • McDonald-McGinn DM, Kirschner R, Goldmuntz E, Sullivan K, Eicher P, Gerdes M, Moss E, Solot C, Wang P, Jacobs I, Handler S, Knightly C, Heher K, Wilson M, Ming JE, Grace K, Driscoll D, Pasquariello P, Randall P, Larossa D, Emanuel BS, Zackai EH. The Philadelphia story: the 22q11.2 deletion: report on 250 patients. Genet Couns. 1999;10:11–24. [PubMed]
  • Merscher S, Funke B, Epstein JA, Heyer J, Puech A, Lu MM, Xavier RJ, Demay MB, Russell RG, Factor S, Tokooya K, Jore BS, Lopez M, Pandita RK, Lia M, Carrion D, Xu H, Schorle H, Kobler JB, Scambler P, Wynshaw-Boris A, Skoultchi AI, Morrow BE, Kucherlapati R. TBX1 is responsible for cardiovascular defects in velo-cardio-facial/DiGeorge syndrome. Cell. 2001;104:619–629. [PubMed]
  • Moore KL, Persaud TVN. The Pharyngeal Apparatus. In: Moore KL, Persaud TVN, editors. Before We Are Born: Essentials of Embryology and Birth Defects, 6e. Saunders; Philadelphia: 2003. pp. 151–187.
  • Paylor R, Glaser B, Mupo A, Ataliotis P, Spencer C, Sobotka A, Sparks C, Choi CH, Oghalai J, Curran S, Murphy KC, Monks S, Williams N, O'Donovan MC, Owen MJ, Scambler PJ, Lindsay E. Tbx1 haploinsufficiency is linked to behavioral disorders in mice and humans: implications for 22q11 deletion syndrome. Proc Natl Acad Sci U S A. 2006;103:7729–7734. [PubMed]
  • Rauch A, Devriendt K, Koch A, Rauch R, Gewillig M, Kraus C, Weyand M, Singer H, Reis A, Hofbeck M. Assessment of association between variants and haplotypes of the remaining TBX1 gene and manifestations of congenital heart defects in 22q11.2 deletion patients. J Med Genet. 2004;41:e40. [PMC free article] [PubMed]
  • Reiter R, Brosch S, Wefel H, Schlomer G, Haase S. The submucous cleft palate: diagnosis and therapy. International J Pediatric Otorhinolaryngology. 2011;75:85–88. [PubMed]
  • Shprintzen RJ, Goldberg RB, Lewin ML, Sidoti EJ, Berkman MD, Argamaso RV, Young D. A new syndrome involving cleft palate, cardiac anomalies, typical facies, and learning disabilities: velo-cardio-facial syndrome. Cleft Palate J. 1978;15:56–62. [PubMed]
  • Torres-Juan L, Rosell J, Morla M, Vidal-Pou C, Garcia-Algas F, de la Fuente MA, Juan M, Tubau A, Bachiller D, Bernues M, Perez-Granero A, Govea N, Busquets X, D Heine-Suner. Mutations in TBX1 genocopy the 22q11.2 deletion and duplication syndromes: a new susceptibility factor for mental retardation. Eur J Hum Genet. 2007;15:658–663. [PubMed]
  • Yagi H, Furutani Y, Hamada H, Sasaki T, Asakawa S, Minoshima S, Ichida F, Joo K, Kimura M, Imamura S, Kamatani N, Momma K, Takao A, Nakazawa M, Shimizu N, Matsuoka R. Role of TBX1 in human del22q11.2 syndrome. Lancet. 2003;362:1366–1373. [PubMed]
  • Zweier C, Sticht H, Aydin-Yaylagul I, Campbell CE, Rauch A. Human TBX1 missense mutations cause gain of function resulting in the same phenotype as 22q11.2 deletions. Am J Hum Genet. 2007;80:510–517. [PubMed]